Article

Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters.

Department of Molecular Biology, Jessenius Faculty of Medicine, Comenius University and Faculty Hospital, Martin, Slovak Republic.
Neoplasma (impact factor: 1.44). 01/2010; 57(1):35-40.
Source: PubMed

ABSTRACT Breast cancer is one of the most common cancer affecting women and the recent research is focused on identifying new genetic and epigenetic prognostic and predictive factors. Glutathione S-transferase P1 (GSTP1) is abiotransformation enzyme expressed in normal breast epithelial cells which can be epigenetically inactivated in breast cancer. We have shown, that application of nested two-stage methylation-specific PCR (MSP) is asuitable method for analysis of epigenetically silenced GSTP1 in formalin-fixed paraffin-embedded (FFPE) tissues from breast cancer patients. Of 45 breast tumors, 11 (24, 4%) were found to have methylated GSTP 1promoter region. We were able to demonstrate the correlation between the hypermethylation of the GSTP1 promoter region and histological grade of the tumor (p Keywords: breast cancer, prognostic factors, hypermethylation, GSTP1, methylation-specific PCR.

0 0
 · 
0 Bookmarks
 · 
26 Views

Keywords

45 breast tumors
 
breast cancer
 
breast cancer patients
 
common cancer
 
epigenetic prognostic
 
epigenetically silenced GSTP1
 
formalin-fixed paraffin-embedded
 
Glutathione S-transferase P1
 
GSTP1 promoter region
 
methylated GSTP 1promoter region
 
nested two-stage methylation-specific PCR
 
normal breast epithelial cells
 
predictive factors
 
prognostic factors
 
recent research
 
tumor
 
women